retatrutide study news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide study news today The

10.1016/j.devcel.2019.10.007 13 BurkR

Just the usual and expected GI side effects that come with the GLP-1 RAs, such as nausea, diarrhea, and vomiting

FFA3 is expressed in the enteric sympathetic ganglion (Kimura et al., 2011) and the vagal ganglion (Nhr et al., 2015) and the GLP-1R is expressed in vagal afferent neurons including the nodose ganglion (Zhang et al., 2020), suggesting the possibility of functional interactions between these two receptors at these neuronal locations

This review seeks to highlight emerging evidence that suggests a growing benefit of GLP-1 RAs irrespective of T2DM status in coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and blood pressure

I think there are certain peptides you can take that are really good for hair, skin and nails, like GHK-Cu, which is the copper peptide, something I take, she told Interview magazine